In particular, a close association of BRAF mutation with extrathyroidal extension, lymph node metastasis, and advanced TNM stages III/IV of PTC, which are well-documented risk factors associated with increased rates of recurrence and mortality of thyroid cancer, have been reported [42,43,44,45,46]. The gene discussed is BRAF; the disease is thyroid gland carcinoma.